Financials
- Market Capitalization 344.86 M
- Employee 81
- Founded 1999
- CEO N/A
- Website www.agenusbio.com
- Headquarter Delaware, United States
- FIGI BBG000C8SWQ9
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
—
市销率
0.82
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3173 | LYEL Lyell Immunopharma, Inc. - Common Stock | 14.53 USD | -0.55% | -5.03% | +7.63% | -39.93% | 356.06 M USD | ||
| 3190 | PALI Palisade Bio, Inc. - Common Stock | 2.00 USD | -5.21% | -4.31% | +3.09% | +17.65% | 348.54 M USD | ||
| 3200 | SABS SAB Biotherapeutics, Inc. - Common Stock | 3.79 USD | -3.56% | +1.07% | +6.46% | +83.98% | 344.84 M USD | ||
| 3201 | DMAC DiaMedica Therapeutics Inc. - Common Stock | 6.39 USD | -5.33% | -2.14% | -1.84% | +11.91% | 344.59 M USD |